Evidence map›Paper›PMID 29946274›Full record

ArticleFrontiers in psychiatry2018

Cognitive Behavioral Therapy for Insomnia as Adjunctive Therapy to Antipsychotics in Schizophrenia: A Case Report.

Muneto Izuhara, Hiroyuki Matsuda, Ami Saito, Maiko Hayashida, Syoko Miura, Arata Oh-Nishi, Ilhamuddin Abdul Azis, Rostia Arianna Abdullah, Keiko Tsuchie, Tomoko Araki and 6 more

Open access · goldAbstract readCase Reports
In one paragraph

Article in Frontiers in psychiatry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.7field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 1 institution in 1 country.

Muneto IzuharaDepartment of Psychiatry, Faculty of Medicine, Shimane University, Izumo, Japan.
Hiroyuki MatsudaDepartment of Psychiatry, Faculty of Medicine, Shimane University, Izumo, Japan.
Ami SaitoDepartment of Psychiatry, Faculty of Medicine, Shimane University, Izumo, Japan.
Maiko HayashidaDepartment of Psychiatry, Faculty of Medicine, Shimane University, Izumo, Japan.
Syoko MiuraDepartment of Psychiatry, Faculty of Medicine, Shimane University, Izumo, Japan.
Arata Oh-NishiDepartment of Psychiatry, Faculty of Medicine, Shimane University, Izumo, Japan.
Ilhamuddin Abdul AzisDepartment of Psychiatry, Faculty of Medicine, Shimane University, Izumo, Japan.
Rostia Arianna AbdullahDepartment of Psychiatry, Faculty of Medicine, Shimane University, Izumo, Japan.
Keiko TsuchieDepartment of Psychiatry, Faculty of Medicine, Shimane University, Izumo, Japan.
Tomoko ArakiDepartment of Psychiatry, Faculty of Medicine, Shimane University, Izumo, Japan.
Arauchi RyousukeDepartment of Psychiatry, Faculty of Medicine, Shimane University, Izumo, Japan.
Misako KanayamaDepartment of Psychiatry, Faculty of Medicine, Shimane University, Izumo, Japan.
Sadayuki HashiokaDepartment of Psychiatry, Faculty of Medicine, Shimane University, Izumo, Japan.
Rei WakeDepartment of Psychiatry, Faculty of Medicine, Shimane University, Izumo, Japan.
Tsuyoshi MiyaokaDepartment of Psychiatry, Faculty of Medicine, Shimane University, Izumo, Japan.
Jun HoriguchiDepartment of Psychiatry, Faculty of Medicine, Shimane University, Izumo, Japan.
Shimane University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The authors present the case of a 38-year-old man with schizophrenia and with severe insomnia, who attempted suicide twice during oral drug therapy with risperidone. The patient slept barely 2 or 3 h per night, and he frequently took half days off from work due to excessive daytime sleepiness. As a maladaptive behavior to insomnia, he progressively spent more time lying in bed without sleeping, and he repeatedly thought about his memories, which were reconstructed from his hallucinations. His relatives and friends frequently noticed that his memories were not correct. Consequently, the patient did not trust his memory, and he began to think that the hallucinations controlled his life. During his insomniac state, he did not take antipsychotic drugs regularly because of his irregular meal schedule due to his excessive daytime sleepiness. The authors started cognitive behavioral therapy for insomnia (CBT-i) with aripiprazole long acting injection (LAI). CBT-i is needed to be tailored to the patient's specific problems, as this case showed that the patient maladaptively use chlorpromazine as a painkiller, and he exercised in the middle of the night because he believed he can fall asleep soon after the exercise. During his CBT-i course, he learned how to evaluate and control his sleep. The patient, who originally wanted to be short sleeper, began to understand that adequate amounts of sleep would contribute to his quality of life. He finally stopped taking chlorpromazine and benzodiazepine as sleeping drugs while taking suvorexant 20 mg. Through CBT-i, he came to understand that poor sleep worsened his hallucinations, and consequently made his life miserable. He understood that good sleep eased his hallucinations, ameliorated his daytime sleepiness and improved his concentration during working hours. Thus, he was able to improve his self-esteem and self-efficacy by controlling his sleep. In this case report, the authors suggest that CBT-i can be an effective therapy for schizophrenia patients with insomnia to the same extent of other psychiatric and non-psychiatric patients.

Indexed as

cognitive behavioral therapycognitive behavioral therapy for insomnia(CBT-i)insomnialong acting injectable antipsychotic(LAI)schizophrenia

Identifiers

PMID29946274
PMCPMC6005892
OpenAlexW2803292206

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.